NCT00850902

Brief Summary

The purpose of this study is to apply a different incubator humidity strategy at birth to decrease morbidity and mortality in extremely low birth (1000 g or less) infants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2009

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 25, 2009

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

March 10, 2009

Status Verified

March 1, 2009

Enrollment Period

1 year

First QC Date

February 23, 2009

Last Update Submit

March 9, 2009

Conditions

Keywords

ELBWHumidityBPD

Outcome Measures

Primary Outcomes (1)

  • Death prior to discharge or Bronchopulmonary Dysplasia (BPD) defined as oxygen requirement at 36 weeks postmenstrual age.

    36 weeks postmenstrual age

Study Arms (2)

Moderate Humidity (MH)

ACTIVE COMPARATOR
Other: Moderate Humidity

High Humidity

EXPERIMENTAL
Other: High Humidity (HH)

Interventions

High Humidity Level

High Humidity

Moderate Humidity Level

Moderate Humidity (MH)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Inborn Premature Infants with weight ≤ 1000 g at birth

You may not qualify if:

  • Outborn infants.
  • Failure to obtain parental consent for the study.
  • Congenital malformations likely to affect life expectancy or neurosensory development.
  • Unlikely to be available for follow up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Jasim Anabrees

    King Fahad Medical City

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

February 23, 2009

First Posted

February 25, 2009

Study Start

March 1, 2009

Primary Completion

March 1, 2010

Study Completion

April 1, 2010

Last Updated

March 10, 2009

Record last verified: 2009-03